LYOPRIME
Live / Registered — Registered (as of 24 Oct 2023)
What this means for you
Registered since 24 Oct 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90237196
- Registration number
- 7202409
- Mark type
- Stylized text
- Filed
- 06 Oct 2020
- Published for opposition
- 19 Oct 2021
- Registered
- 24 Oct 2023
- Attorney of record
- Joseph W. Secondine, Jr.
Goods and services
- Class 001 — Chemicals: Reagents for scientific research use; Reagents for molecular biology and/or cell biology for scientific, research, laboratory or in vitro diagnostic use; Reagents for diagnostic tests and/or diagnostic devices for scientific, research, laboratory or in vitro diagnostic use; Reagents for genetic research, clinical or medical laboratory use; Enzyme reagents for scientific, research, laboratory or in vitro diagnostic use; Enzymes for scientific and/or research use; Enzymes for molecular biology research and/or cell biology scientific and research applications
Owner
- New England Biolabs, Inc., Ipswich, MA, US
- New England Biolabs, Inc., Ipswich, MA, US
- New England Biolabs, Inc., Ipswich, MA, US
Prosecution history
- 24 Oct 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 24 Oct 2023 — REGISTERED-PRINCIPAL REGISTER
- 04 Oct 2023 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 21 Sept 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 20 Sept 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 20 Sept 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 20 Sept 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 20 Sept 2023 — ASSIGNED TO LIE
- 03 May 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 05 Nov 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 05 Nov 2022 — NON-FINAL ACTION E-MAILED
- 05 Nov 2022 — SU - NON-FINAL ACTION - WRITTEN
- 24 Oct 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 07 Oct 2022 — USE AMENDMENT FILED
- 24 Oct 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL